|
| related topics |
| {property, intellectual, protect} |
| {cost, regulation, environmental} |
| {operation, international, foreign} |
| {debt, indebtedness, cash} |
| {stock, price, share} |
| {product, market, service} |
| {personnel, key, retain} |
| {regulation, government, change} |
| {acquisition, growth, future} |
| {product, candidate, development} |
| {financial, litigation, operation} |
| {cost, contract, operation} |
| {customer, product, revenue} |
|
|
Risks Related to the Growth of Our Business
We must continually offer new products and technologies.
Failure to integrate acquired businesses into our operations successfully could adversely affect our business.
Risks Related to Our Sales
Reduction in research and development budgets and government funding may affect sales.
Changing purchasing arrangements with our customers could reduce our profit margins.
Sales of biological and chemical defense materials subject us to certain risks.
Risks Related to the Development and Manufacturing of Our Products
Fluctuation in the price and supply of raw FBS could affect our business.
Failure to license new technologies could impair our new product development.
Loss of licensed rights could hurt our business.
Violation of government regulations or voluntary quality programs could result in loss of revenues and additional expense.
Risks Related to Our Operations
Loss of key personnel could hurt our business.
Litigation may harm our business or otherwise distract our management.
We have a significant amount of debt, which could adversely affect our financial condition.
We could lose the tax deduction on our convertible senior notes due in 2023, the convertible senior notes due in 2024 and the convertible senior notes due in 2025 under certain circumstances.
Risks Related to Our International Operations
International unrest or foreign currency fluctuations could adversely affect our results.
Risks Related to Our Intellectual Property
Inability to protect our technologies could affect our ability to compete.
Disclosure of trade secrets could aid our competitors.
Intellectual property litigation and other litigation could harm our business.
Risks Related to Environmental and Product Liability Issues
We are subject to risks related to handling of hazardous materials and other regulations governing environmental safety.
Potential product liability claims could affect our earnings and financial condition.
Risks Related to the Market for Our Securities
Our operating results and the market price of our stock and convertible notes could be volatile.
Full 10-K form ▸
|
|
| related documents |
| 1073431--3/1/2007--INVITROGEN_CORP |
| 1073431--2/15/2008--INVITROGEN_CORP |
| 1043961--3/28/2008--TRANSGENOMIC_INC |
| 1073431--3/2/2009--Life_Technologies_Corp |
| 1107216--3/15/2007--ORCHID_CELLMARK_INC |
| 1073431--2/26/2010--Life_Technologies_Corp |
| 276283--4/3/2006--EVANS_&_SUTHERLAND_COMPUTER_CORP |
| 1107216--5/24/2006--ORCHID_CELLMARK_INC |
| 1043961--3/31/2006--TRANSGENOMIC_INC |
| 945828--9/28/2010--AMERITYRE_CORP |
| 945828--9/13/2006--AMERITYRE_CORP |
| 945828--9/17/2007--AMERITYRE_CORP |
| 945828--9/15/2008--AMERITYRE_CORP |
| 1001193--3/30/2007--TRANSMETA_CORP |
| 1014672--3/12/2010--CALIPER_LIFE_SCIENCES_INC |
| 1107216--3/12/2008--ORCHID_CELLMARK_INC |
| 924717--12/11/2009--SURMODICS_INC |
| 802356--7/24/2006--PARLUX_FRAGRANCES_INC |
| 1063254--3/16/2006--S1_CORP_/DE/ |
| 1063254--3/4/2008--S1_CORP_/DE/ |
| 924717--12/14/2010--SURMODICS_INC |
| 875045--2/21/2007--BIOGEN_IDEC_INC |
| 875045--2/9/2010--BIOGEN_IDEC_INC. |
| 802356--7/11/2007--PARLUX_FRAGRANCES_INC |
| 924717--12/15/2008--SURMODICS_INC |
| 771999--3/17/2008--DOCUMENT_SECURITY_SYSTEMS_INC |
| 797448--3/31/2006--VERSO_TECHNOLOGIES_INC |
| 1029023--3/17/2008--SYNTROLEUM_CORP |
| 50863--2/22/2010--INTEL_CORP |
| 1145460--3/1/2007--INVERNESS_MEDICAL_INNOVATIONS_INC |
|